BVNRY / 4 Things to Know About Company Making the Monkeypox Vaccine

The U.S. Centers for Disease Control and Prevention is urging people at high risk of mpox to get two doses of Bavarian Nordic's Jynneos vaccine, based more_horizontal

Call Start: 08:00 January 1, 0000 8:50 AM ET Bavarian Nordic A/S (OTCPK:BVNKF) Q1 2023 Earnings Conference Call May 9, 2023 08:00 ET Company Participa more_horizontal

Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare for a smallpox emergency, CEO Paul Chaplin said. more_horizontal

Bavarian Nordic A/S (OTCPK:BVNKF) Q3 2022 Results Conference Call November 9, 2022 8:00 AM ET Company Participants Rolf Sorensen - Investor Relations more_horizontal

Bearish sentiment weighed heavily on the biotech industry and Bavarian Nordic A/S. There is reason for optimism given the current opportunities offere more_horizontal

Source: angellodeco / Shutterstock.com Bavarian Nordic (OTCMKTS: BVNRY ) stock is on the move Wednesday after the vaccine company signed a supply agre more_horizontal

The Centers for Disease Control and Prevention has reported 3,487 monkeypox cases in the U.S. so far. more_horizontal

The U.S.-listed shares of Bavarian Nordic A/S BVNRY, +3.87% BAVA, +0.56% jumped 2.0% in afternoon trading Friday, after the Denmark-based drug maker s more_horizontal